UOC
ZURA icon

UBS O'Connor’s Zura Bio ZURA Stock Holding History

UBS O'Connor’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-80,912
Closed -$202K – 484
2024
Q4 		$202K Hold
80,912
– – 0.01% 332
2024
Q3 		$329K Buy
80,912
+7,516
+10% +$28.1K 0.01% 367
2024
Q2 		$257K Buy
+73,396
New +$299K 0.01% 409
2023
Q4 		– Sell
-167,167
Closed -$1.1M – 614
2023
Q3 		$1.1M Hold
167,167
– – 0.02% 321
2023
Q2 		$1.37M Buy
+167,167
New +$1.34M 0.03% 348
2022
Q4 		– Sell
-238,623
Closed -$2.4M – 350
2022
Q3 		$2.4M Sell
238,623
-23,888
-9% -$239K 0.03% 520
2022
Q2 		$2.61M Buy
+262,511
New +$2.61M 0.03% 520
2022
Q1 		– Sell
-257,885
Closed -$2.54M – 244
2021
Q4 		$2.54M Buy
257,885
+6,906
+3% +$68.2K 0.02% 468
2021
Q3 		$2.47M Buy
+250,979
New +$2.46M 0.02% 472

Other funds holding ZURA

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

UBS O'Connor's ZURA Position: Q1 2025 in Review

UBS O'Connor sold out of Zura Bio (ZURA) in Q1 2025, closing a stake of 80,912 shares — an estimated $202K sold.

UBS O'Connor first reported a position in ZURA in Q3 2021 and held it in 9 quarters. The position peaked at $2.61M in Q2 2022. 74 funds tracked by Wall St. Rank hold ZURA as of Q1 2025.

  • UBS O'Connor reported no remaining Zura Bio position as of Q1 2025 after selling out during the quarter.
  • UBS O'Connor sold 80,912 Zura Bio shares in Q1 2025, an estimated $202K.
  • UBS O'Connor first reported a position in Zura Bio in Q3 2021 and held it in 9 quarters.
  • UBS O'Connor's Zura Bio position peaked at $2.61M in Q2 2022.
  • 74 funds tracked by Wall St. Rank held Zura Bio as of Q1 2025.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.